Daniel Spratt

63PUBLICATIONS
274CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersRadiation therapyHaematological tumoursPacific Peoples tourism
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (63)

|May 28, 2026
EMETPRO: a multicentric, international, retrospective analysis evaluating patients with metastatic hormone-sensitive prostate cancer with early progression.

|Apr 30, 2026
Trends in Long-Term Survival Among Patients With De Novo Metastatic Cancer.

|Apr 29, 2026
Real-world treatment patterns in patients with biochemical recurrence after local prostate cancer therapy.

|Feb 19, 2026
Apalutamide + Abiraterone Acetate plus Prednisone + Leuprolide with Stereotactic, Ultra-Hypofractionated Radiation in Very High-Risk Prostate Cancer: A Single-Arm, Phase 2 Study.

Sean M McBride, Daniel E Spratt, Marisa Kollmeier

|Dec 20, 2025
Association of race and survival in patients treated with apalutamide: Pooled analysis of two phase 3 trials.

Georges Gebrael, Neeraj Agarwal, Alicia K Morgans

|Dec 16, 2025
Early favorable prostate-specific antigen response prediction in metastatic hormone sensitive prostate cancer.

Soumyajit Roy, Yilun Sun, Maha Hussain

Pageof 11

Frequent Collaborators

10 joint publications

Robert T Dess

9 joint publications

Randy Vince

9 joint publications

Felix Y Feng

9 joint publications

Amar U Kishan